Should we still have bare-metal stents available in our catheterization laboratory?
A Colombo, F Giannini, C Briguori - Journal of the American College of …, 2017 - jacc.org
The introduction of bare-metal stents (BMS) has represented a major advancement over
plain old balloon angioplasty in the management of coronary artery disease. However, the …
plain old balloon angioplasty in the management of coronary artery disease. However, the …
Update on direct oral anticoagulants in atrial fibrillation patients undergoing cardiac interventional procedures: from clinical trials to real-world evidence
E Melillo, A Carbone, A Rago, AA Papa… - Journal of …, 2020 - journals.lww.com
Direct oral anticoagulants (DOACs) are considered a first-line therapy for long-term stroke
prevention in patients with nonvalvular atrial fibrillation (AF) and high thromboembolic risk …
prevention in patients with nonvalvular atrial fibrillation (AF) and high thromboembolic risk …
Influence of atrial fibrillation on outcomes in patients who underwent primary percutaneous coronary intervention for ST-segment elevation myocardial infarction
Atrial fibrillation (AF) is a common co-morbidity among patients presenting with acute ST-
segment elevation myocardial infarction (STEMI). Previously, small studies have reported an …
segment elevation myocardial infarction (STEMI). Previously, small studies have reported an …
Early Neointimal Coverage and Vasodilator Response Following Biodegradable Polymer Sirolimus-Eluting vs. Durable Polymer Zotarolimus-Eluting Stents in Patients …
PP Karjalainen, V Varho, W Nammas… - Circulation …, 2015 - jstage.jst.go.jp
Background: Patients at high bleeding risk would benefit from a shorter dual antiplatelet
therapy after PCI. Compared to first-generation devices, the design of newer generation …
therapy after PCI. Compared to first-generation devices, the design of newer generation …
Effects of triple therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention regarding thromboembolic risk stratification
A Sambola, M Mutuberría, BG Del Blanco… - Circulation …, 2016 - jstage.jst.go.jp
Background: The effects of dual antiplatelet therapy (DAPT) and triple therapy (TT: DAPT
plus oral anticoagulation) in patients with atrial fibrillation (AF) undergoing percutaneous …
plus oral anticoagulation) in patients with atrial fibrillation (AF) undergoing percutaneous …
Bridging therapy with low molecular weight heparin in patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: the AFCAS …
Background Recent reports have provided evidence that bridging therapy with low-
molecular-weight heparin (LMWH) may increase bleeding complications in patients with …
molecular-weight heparin (LMWH) may increase bleeding complications in patients with …
Medikamentenfreisetzende Koronarstents/-scaffolds und medikamentenbeschichtete Ballonkatheter
HM Nef, M Abdel-Wahab, S Achenbach… - Die …, 2018 - search.proquest.com
Abstract Die rasante Entwicklung der Stenttechnologien seit Einführung der perkutanen
Katheterintervention vor 40 Jahren erfordert eine stetige Weiterbildung des interventionell …
Katheterintervention vor 40 Jahren erfordert eine stetige Weiterbildung des interventionell …
Antithrombotic treatment in atrial fibrillation patients undergoing percutaneous coronary interventions: focus on stent thrombosis
M Vitolo, S Javed, D Capodanno… - Expert Review of …, 2020 - Taylor & Francis
Introduction Coronary artery disease (CAD) commonly coexists with atrial fibrillation (AF),
requiring oral anticoagulation (OAC) in a significant subset of patients. These patients also …
requiring oral anticoagulation (OAC) in a significant subset of patients. These patients also …
[PDF][PDF] Patients with atrial fibrillation undergoing percutaneous coronary intervention
MS Dzeshka, RA Brown, GYH Lip - Polskie Archiwum Medycyny …, 2015 - core.ac.uk
Atrial fibrillation (AF) and coronary artery disease (CAD) often coexist. Both conditions confer
an increased risk of acute thrombotic complications. However, the pathogenesis of thrombus …
an increased risk of acute thrombotic complications. However, the pathogenesis of thrombus …
Clinical Outcomes of Drug-Eluting Stents vs. Bare-Metal Stents in Acute Myocardial Infarction Patients Under Dialysis–A Nationwide Cohort Study–
Background: Data on the cardiovascular (CV) outcomes of drug-eluting stents (DES) vs.
bare-metal stents (BMS) in patients with acute myocardial infarction (AMI) under dialysis are …
bare-metal stents (BMS) in patients with acute myocardial infarction (AMI) under dialysis are …